Navigation Links
Bederra Corporation Retains OTC Financial Network for Investor Relations
Date:7/7/2008

HOUSTON, July 7 /PRNewswire-FirstCall/ -- Bederra Corporation (Pink Sheets: BDRR), a medical imaging and diagnostic company, announced today that it has retained OTC Financial Network (OTCFN), a division of National Financial Communications Corp., for a comprehensive investor relations campaign.

Geoffrey Eiten, president of OTCFN, said, "In 2007, Bederra generated revenues of approximately $1.8 million and net earnings of $471,182, or approximately $0.01 per share, and has some very exciting prospects for continued growth."

"The city of Houston is the fourth largest in the U.S. With national health care costs on the rise and hospital budgets tightening, Bederra offers cost-effective outsourced services to local area health care clinics and doctors. The Company plans to expand its market niche to develop a diversified health care company to better serve the over 5 million residents in Houston. This business model can be replicated to other cities over the long-term. We look forward to helping the Company increase investor awareness as it undertakes its aggressive growth-through-acquisition strategy to achieve its goals," added Eiten.

Graham Williams, CEO of Bederra Corporation, said, "We look forward to building relationships with patients to provide them with comprehensive, affordable health care, from our current diagnostic and medical imaging to pharmacies, walk-in clinics and mobile vans that provide 'check-ups.' We have identified a number of potential acquisitions that could provide these services, while growing our top- and bottom-line. As we reach key milestones, OTC Financial Network will play an important role in increasing our visibility in the financial community and helping us move toward a fully reporting status."

About OTC Financial Network

Since its inception in 1992, OTC Financial Network (OTCFN), a division of National Financial Communications Corp. (http://www.nationalfc.com), has carved its niche as the nation's leading small/micro-cap investor relations and financial communications firm. For more information, visit http://www.otcfn.com.

About Bederra Corporation

Bederra Corporation, which wholly owns Diagnos, Inc. and Lumar Imaging, Inc., provides multiple modality diagnostic medical imaging services to the greater Houston area and world famous Texas medical center. The company's current strategy is to grow its current operations and seek out additional acquisitions that will complement its core operations.

OTC Financial Network (OTCFN) serves as special advisor to the featured Company and has received fees for services, including three million six hundred thousand shares of common stock for payment of a monthly retainer of five thousand dollars for three months, plus expenses, for the creation and distribution of materials. This is not an offer to buy or sell securities. Information or opinions in this release are presented solely for informative purposes, and are not intended, nor should they be construed, as investment advice. A full disclaimer can be found online by visiting http://www.otcfn.com/bdrr/disclaimer.html.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.


'/>"/>
SOURCE Bederra Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
2. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
3. Chem Rx Corporation Surpasses 67,000 Beds Served
4. Air Methods Corporation Confirms Mid-Air Collision in Arizona
5. Vystar Corporation Announces Agreement with Kildare Capital to Provide Investment Banking Services
6. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
7. Oregon Based First Pacific Corporation Launches New E-Tools Program for Dentists
8. CRH Medical Corporation opens Center in San Diego California
9. uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series
10. Zix Corporation Processes More Than 20 Million Electronic Prescriptions
11. Chem Rx Corporation Appoints Gary M. Jacobs Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: